Colin Walsh - Jun 24, 2021 Form 3 Insider Report for Elevation Oncology, Inc. (ELEV)

Role
Director
Signature
/s/ Shawn Leland, Attorney-in-Fact
Stock symbol
ELEV
Transactions as of
Jun 24, 2021
Transactions value $
$0
Form type
3
Date filed
6/24/2021, 06:01 PM
Next filing
Jun 22, 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.